cT1N0M0期食管癌内镜下非治愈性切除的研究进展  

Research advancements in non-curative endoscopic resection of cT1N0M0 esophageal cancer

作　　者：吴振坤(综述) 王贵齐(审校) Zhenkun Wu;Guiqi Wang(Department of Endoscopy,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院内镜科,北京市100021

出　　处：《中国肿瘤临床》2024年第5期253-257,共5页Chinese Journal of Clinical Oncology

基　　金：中国医学科学院医学与健康科技创新工程项目(编号:2021-I2M-1-061、2021-I2M-1-013、2021-I2M-1-015和2022-I2M-C&T-B-054);深圳市医疗卫生"三名工程"项目(编号:SZSM201911008);首都卫生发展科研专项项目(编号:首发2020-2-4025);中国癌症基金会北京希望马拉松专项基金项目(编号:LC2021A03)资助。

摘　　要：随着消化内镜诊疗活动的广泛开展,内镜下切除已成为cT1N0M0期食管癌的标准治疗方案之一。然而,术后病理确认的非治愈性切除患者仍然面临复杂的后续管理选择。本文就cT1N0M0期食管癌内镜下非治愈性切除的国内外研究进展进行综述,指出现有指南有关非治愈性切除的定义尚存争议,同时针对这部分患者,应在临床实践中制定选择性的个体化管理策略。Endoscopic resection has become one of the standard treatment options for cT1N0M0 esophageal cancer owing to the wide-spread use of digestive endoscopy.However,patients who undergo non-curative resection,as confirmed by postoperative pathology invest-igations,encounter complex decisions regarding follow-up management.This paper reviews the advancements in domestic and internation-al research on non-curative endoscopic resection of cT1N0M0 esophageal cancer,highlighting the controversy surrounding the current guidelines for the definition of non-curative resection.In addition,it emphasizes on the formulation of individualized management strategies for these patients in routine clinical practice.

关 键 词：内镜下切除 内镜黏膜下剥离术 非治愈性切除 cT1N0M0期 食管鳞癌 

分 类 号：R735.1[医药卫生—肿瘤]